How Many Humans Do Snails Kill a Year?

Freshwater snails are estimated to cause around 200,000 human deaths every year, placing them among the deadliest animals on the planet. Snails do not bite, sting, or attack; they serve as the biological middleman for parasitic worms that cause schistosomiasis, a disease affecting more than 200 million people globally. The gap between the humble reputation of a snail and the scale of death it enables is one of the most striking disconnects in public health.

Why Snails, of All Things

Snails kill indirectly. The culprits are specific species of freshwater snails that act as intermediate hosts for parasitic flatworms in the genus Schistosoma. The parasites have a two-host life cycle: they need both a snail and a human to reproduce. When infected people urinate or defecate near fresh water, parasite eggs reach the water and hatch into tiny larvae called miracidia. Those larvae seek out and burrow into particular snail species. Inside the snail, they multiply dramatically. A single infected snail can shed hundreds of the next larval stage, called cercariae, into the water every day: roughly 200 per day for one species, and as many as 600 per day for another.¹ These cercariae penetrate human skin on contact with contaminated water, entering the bloodstream and eventually settling in veins around the intestines or bladder, where the cycle starts again.

Different Schistosoma species depend on different snail genera. S. haematobium, which causes urinary schistosomiasis, relies on Bulinus snails. S. mansoni, common in Africa and parts of South America, uses Biomphalaria snails. S. japonicum, found in East and Southeast Asia, depends on Oncomelania snails.¹ The snails themselves are small, unassuming freshwater creatures. They do not seek out humans. The entire danger arises because people and snails share the same water sources, whether for bathing, washing clothes, farming, fishing, or swimming.

Where Most of the Deaths Happen

Schistosomiasis is overwhelmingly an African problem. Sub-Saharan Africa accounts for about 93% of the world’s estimated 207 million cases, with Nigeria alone carrying roughly 29 million infections. Tanzania, Ghana, and the Democratic Republic of Congo follow close behind.² The disease also persists in parts of the Middle East, South America, Southeast Asia, and China, but the African continent bears the vast majority of the burden.

Within Africa, the distribution is uneven. According to the Global Burden of Disease Study 2021, West Africa had the highest prevalence rates, while Central Africa had the highest age-standardized mortality rate at about 3 per 100,000 people. North Africa, by contrast, had the lowest mortality rate, roughly a tenth of that.³ Countries like Côte d’Ivoire and the Republic of Congo sit in clusters of high prevalence and high death rates, while Algeria and other North African nations have largely controlled the disease.

The Bulinus snail genus alone is endemic across Angola, Benin, Chad, Côte d’Ivoire, Egypt, Ethiopia, Ghana, Kenya, Nigeria, Senegal, South Africa, Sudan, Tanzania, Uganda, and several other nations, giving a sense of the geographic reach of just one branch of the transmission chain.⁴

How Schistosomiasis Actually Kills

Most people who die from schistosomiasis do not die quickly. The disease is chronic. When schistosome worms settle in the body’s veins, they produce eggs. Many of those eggs get trapped in tissue, especially in the liver, intestines, and bladder. The immune system mounts an inflammatory response against these trapped eggs, and over years, that inflammation causes progressive organ damage.

The complications are serious and wide-ranging: irreversible pulmonary hypertension, kidney and urinary tract damage, central nervous system involvement, and an increased risk of certain cancers, particularly bladder cancer in the case of S. haematobium.⁵ Liver fibrosis is one of the most common severe outcomes: the liver gradually scars from the immune response to eggs accumulating in its blood vessels, leading to portal hypertension and eventually life-threatening internal bleeding from ruptured veins in the esophagus. In children, chronic infection stunts growth and impairs cognitive development long before any lethal complication sets in.

Because the disease kills slowly, its death toll is harder to measure than that of a fast-acting infection like malaria. People who die from liver failure or kidney disease caused by schistosomiasis may not have schistosomiasis listed on their death certificates, which means the 200,000-per-year estimate is itself likely conservative. The true number could be higher, but undercounting is a feature of neglected tropical diseases in regions with limited health surveillance.

Why the Problem Persists

Schistosomiasis is often called a disease of poverty, and the label fits. Transmission is tightly linked to water and sanitation infrastructure. People get infected because they have to use natural water sources for daily life. In rural and peri-urban communities across sub-Saharan Africa, reliable piped water is scarce. Farming, fishing, bathing, and laundry all require contact with rivers, lakes, and irrigation canals where infected snails live. Researchers studying risk factors in urban areas of Côte d’Ivoire found that reducing schistosomiasis required a combination of health education, behavior change, and improved sanitation and water infrastructure to limit contact with contaminated surface water.⁶

This creates a frustrating loop. The disease impoverishes the communities it hits, keeping children out of school and adults too ill to work, which in turn makes it harder for those communities to invest in the infrastructure that would break the cycle. Schistosomiasis does not generate the same urgency as diseases with dramatic acute presentations, so it has historically attracted less funding and political attention. It is classified as a neglected tropical disease by the World Health Organization for exactly this reason.

Treatment Exists but Has Limits

The drug praziquantel is the backbone of schistosomiasis control worldwide. A single oral dose is the standard treatment, and mass drug administration campaigns target school-age children in endemic areas. In a study of preschool-age children infected with S. mansoni in Ethiopia, a single dose of praziquantel achieved an egg reduction rate of about 93% and cured roughly 85% of participants. The drug was generally well tolerated, with side effects that were mostly mild and short-lived.⁷

Those numbers sound encouraging, but the picture is more complicated. Cure rates drop sharply with heavier infections: in the same study, only about 29% of heavily infected children were cured by a single dose, compared to 100% of those with light infections.⁷ Praziquantel also does not prevent reinfection. In communities where people continue to contact contaminated water daily, reinfection rates are high, and children may need to be treated repeatedly year after year. There is also growing concern about whether relying on a single drug indefinitely could eventually select for resistant parasites, though significant resistance has not yet been confirmed in the field.

Preschool-age children, who are among the most vulnerable, have historically been excluded from mass treatment campaigns because of limited data on how the drug works in very young bodies. Recent research is pushing to change that, with studies demonstrating that praziquantel is safe and effective enough in preschoolers to justify their inclusion in national deworming programs.⁷

The Vaccine Question

A vaccine against schistosomiasis would be transformative, but one does not yet exist. Several candidates are in clinical development, and the field is exploring newer technologies including mRNA vaccine platforms and CRISPR-based approaches for vaccine discovery and design.⁸ The biology of schistosome worms makes vaccine development difficult. These parasites are large, complex organisms that have evolved sophisticated ways to evade the human immune system, including coating themselves in host molecules to avoid detection. Unlike viruses with a handful of surface proteins, schistosomes present a much more complicated target.

Even a partially effective vaccine could make a meaningful dent in the death toll if it reduced worm burdens enough to prevent the severe chronic complications that lead to death. The hope is that a vaccine, combined with drug treatment and water infrastructure improvements, could eventually push the disease toward elimination in some regions. For now, though, mass drug administration remains the primary tool.

Climate Change Is Redrawing the Map

The geographic reach of schistosomiasis is not static. Climate change is expected to shift where the disease thrives by altering temperatures, rainfall, and the availability of freshwater habitats where snails breed. Rising temperatures could expand the range of snail populations into areas that were previously too cool, including higher-altitude regions in East Africa and parts of southern Europe. At the same time, some currently endemic areas may become too hot and dry for snails, potentially reducing transmission in parts of West Africa.⁹

Extreme weather events add another layer of unpredictability. Flooding can spread snails and parasites into new water systems, while drought can concentrate people and snails in the same shrinking water sources. The net effect is that the disease is likely to become harder to control as environmental conditions fluctuate, creating new pockets of transmission in regions that have no experience managing it and no surveillance systems to catch early cases.

Other Snail-Transmitted Diseases

Schistosomiasis dominates the death toll, but it is not the only dangerous infection linked to snails. Rat lungworm disease, caused by the parasite Angiostrongylus cantonensis, is the most common cause of a type of brain inflammation called eosinophilic meningitis worldwide. People get infected by eating raw or undercooked freshwater snails or slugs, or by eating produce contaminated with snail slime containing parasite larvae.¹⁰

The larvae travel to the brain, where they can cause severe neurological damage including headaches, nerve palsies, and abnormal sensations. Fatal cases do occur but are rare; most people recover, though some are left with lasting neurological problems.¹¹ Rat lungworm disease is endemic throughout the Asia-Pacific region and has been spreading to new areas, including parts of the southeastern United States, the Caribbean, and Brazil, partly due to the global spread of invasive snail and slug species that can serve as hosts.

The risk from rat lungworm is far smaller than from schistosomiasis in terms of total deaths, but it catches attention because it can affect travelers and residents in wealthier countries. Cases in Hawaii, for instance, have drawn media attention, and health authorities there warn against eating raw snails or unwashed produce. Unlike schistosomiasis, which requires skin contact with contaminated water, rat lungworm is primarily a food safety issue.

A Disease Older Than Written History

Schistosomiasis is not a modern problem. Ancient Egyptian medical papyri describe symptoms consistent with the disease, and some scholars have linked biblical descriptions of epidemic “curses” to possible schistosomiasis outbreaks in Mesopotamia.¹² In Japan, the disease was recognized as far back as 1847 in a regional medical memoir, long before the parasite’s life cycle was understood.¹³ Japan ultimately succeeded in eliminating the disease by the 1990s through a combination of snail control, environmental management, and treatment, making it one of the few countries to fully eradicate schistosomiasis. That success story shows the disease is beatable, but it required decades of sustained effort and investment that most affected countries today cannot easily replicate.

Cone Snails and the Other Side of Snail Danger

When people picture a “deadly snail,” they sometimes think of cone snails, the marine predators whose venomous harpoons can kill a human in rare cases. Cone snails are a genuinely separate category of danger. They are ocean-dwelling, beautifully patterned shells that hunt fish and worms using venom-loaded darts. A handful of the roughly 900 known cone snail species produce venom potent enough to be dangerous to humans, and a few deaths have been recorded over the years, almost always involving people who picked up the shells while beachcombing or diving.

The irony is that cone snail venom has become medically valuable. The venom contains hundreds of small peptides called conotoxins, some of which target pain-signaling pathways in the nervous system with extraordinary precision. One cone snail compound, ziconotide, is already approved as a pain medication for severe chronic pain, and researchers continue to explore cone snail venoms as a pipeline for discovering non-opioid pain treatments.¹⁴ Cone snail deaths are vanishingly rare compared to the schistosomiasis toll, numbering in the single digits in any given year worldwide, but they represent the only cases where a snail itself directly kills a person rather than acting as a parasite’s host.

The contrast highlights something important about the original question. Almost none of the roughly 200,000 annual snail-associated deaths involve a snail doing anything aggressive. The freshwater snails that transmit schistosomiasis are passive participants in a parasitic life cycle. They do not seek out humans. They sit in warm, shallow water, doing what snails do, while the parasites they harbor exploit the overlap between snail habitat and human activity. The deadliness is environmental and systemic, a product of poverty, inadequate water infrastructure, and a parasite that has evolved to move between two hosts with ruthless efficiency.